Mutations in CEP57 cause mosaic variegated aneuploidy syndrome

[1]  J. Shendure,et al.  Massively parallel sequencing and rare disease. , 2010, Human molecular genetics.

[2]  Emily H Turner,et al.  Exome sequencing identifies MLL2 mutations as a cause of Kabuki syndrome , 2010, Nature Genetics.

[3]  N. Rahman,et al.  Molecular causes for BUBR1 dysfunction in the human cancer predisposition syndrome mosaic variegated aneuploidy. , 2010, Cancer research.

[4]  P. Bork,et al.  A method and server for predicting damaging missense mutations , 2010, Nature Methods.

[5]  H. Prats,et al.  Pivotal Role of Translokin/CEP57 in the Unconventional Secretion Versus Nuclear Translocation of FGF2 , 2009, Traffic.

[6]  D. Cleveland,et al.  Boveri revisited: chromosomal instability, aneuploidy and tumorigenesis , 2009, Nature Reviews Molecular Cell Biology.

[7]  P. Barros-Núñez,et al.  Clinical and genetic heterogeneity in patients with mosaic variegated aneuploidy: Delineation of clinical subtypes , 2008, American journal of medical genetics. Part A.

[8]  Angelika Amon,et al.  Aneuploidy: Cells Losing Their Balance , 2008, Genetics.

[9]  T. Miyake,et al.  Cep57, a multidomain protein with unique microtubule and centrosomal localization domains. , 2008, The Biochemical journal.

[10]  E. Salmon,et al.  The spindle-assembly checkpoint in space and time , 2007, Nature Reviews Molecular Cell Biology.

[11]  N. Rahman,et al.  Constitutional aneuploidy and cancer predisposition caused by biallelic mutations in BUB1B , 2004, Nature Genetics.

[12]  M. Mann,et al.  Proteomic characterization of the human centrosome by protein correlation profiling , 2003, Nature.

[13]  P. Galvin-Parton,et al.  Mosaic variegated aneuploidy with growth hormone deficiency and congenital heart defects. , 2002, American journal of medical genetics.

[14]  S. Henikoff,et al.  Predicting deleterious amino acid substitutions. , 2001, Genome research.

[15]  J. Teague,et al.  COSMIC: the catalogue of somatic mutations in cancer , 2011, Genome Biology.